Home - Products - Autophagy - CXCR - Syringaresinol-di-O-glucoside

Syringaresinol-di-O-glucoside

CAS No. 66791-77-3

Syringaresinol-di-O-glucoside( —— )

Catalog No. M18972 CAS No. 66791-77-3

1. Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 In Stock
10MG 169 In Stock
25MG 286 In Stock
50MG 422 In Stock
100MG 620 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Syringaresinol-di-O-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    1. Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.
  • Description
    Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    CXCR
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    66791-77-3
  • Formula Weight
    742.72
  • Molecular Formula
    C34H46O18
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC1=CC(=CC(=C1OC2C(C(C(C(O2)CO)O)O)O)OC)C3C4COC(C4CO3)C5=CC(=C(C(=C5)OC)OC6C(C(C(C(O6)CO)O)O)O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CTCE 9908

    CXCR4 antagonist; induces mitotic catastrophe in ovarian cancer cells. Displays additive cytotoxic effects when given with taxol. Enhances the efficacy of docetaxel in a mouse model.

  • Mogamulizumab

    Mogamulizumab (KW-0761) is a monoclonal antibody targeting T cell CC chemokine receptor 4.

  • NUCC-390

    NUCC-390, a novel small-molecule CXCR4 receptor agonist, selectively induces CXCR4 receptor internalization while acting antagonistically to AMD3100.